Literature DB >> 11711598

Restoration of wild-type infectivity to human immunodeficiency virus type 1 strains lacking nef by intravirion reverse transcription.

M Khan1, M Garcia-Barrio, M D Powell.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) Nef protein exerts several effects, both on infected cells and as a virion protein, which work together to enhance viral replication. One of these activities is the ability to enhance infectivity and the formation of proviral DNA. The mechanism of this enhancement remains incompletely understood. We show that virions with nef deleted can be restored to wild-type infectivity by stimulating intravirion reverse transcription. Particle composition and measures of reverse transcriptase activity remain the same for Nef(+) and Nef(-) virions both before and after natural endogenous reverse transcription (NERT) treatment. The effect of NERT treatment on virions pseudotyped with murine leukemia virus envelope protein was similar to that on particles pseudotyped with HIV-1 envelope protein. However, virions pseudotyped with vesicular stomatitis virus G envelope protein showed no influence of Nef on NERT enhancement of infectivity. These observations suggest that Nef may function at a level prior to reverse transcription. Since NERT treatment results in partial disassembly of the viral core, we speculate that Nef may function at the level of core particle disassembly.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11711598      PMCID: PMC116103          DOI: 10.1128/JVI.75.24.12081-12087.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  The Nef protein of HIV-1 associates with rafts and primes T cells for activation.

Authors:  J K Wang; E Kiyokawa; E Verdin; D Trono
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

2.  Interaction of HIV-1 Nef with the cellular dileucine-based sorting pathway is required for CD4 down-regulation and optimal viral infectivity.

Authors:  H M Craig; M W Pandori; J C Guatelli
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

Review 3.  Natural endogenous reverse transcription of HIV-1.

Authors:  H Zhang; G Dornadula; R J Pomerantz
Journal:  J Reprod Immunol       Date:  1998-12       Impact factor: 4.054

Review 4.  The Nef protein of primate lentiviruses.

Authors:  V Piguet; D Trono
Journal:  Rev Med Virol       Date:  1999 Apr-Jun       Impact factor: 6.989

5.  Nef enhances human immunodeficiency virus replication and responsiveness to interleukin-2 in human lymphoid tissue ex vivo.

Authors:  S Glushakova; J C Grivel; K Suryanarayana; P Meylan; J D Lifson; R Desrosiers; L Margolis
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

6.  Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner.

Authors:  J Lama; A Mangasarian; D Trono
Journal:  Curr Biol       Date:  1999-06-17       Impact factor: 10.834

7.  Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein.

Authors:  T M Ross; A E Oran; B R Cullen
Journal:  Curr Biol       Date:  1999-06-17       Impact factor: 10.834

8.  Association of Nef with the human immunodeficiency virus type 1 core.

Authors:  A Kotov; J Zhou; P Flicker; C Aiken
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

9.  HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages.

Authors:  S Swingler; A Mann; J Jacqué; B Brichacek; V G Sasseville; K Williams; A A Lackner; E N Janoff; R Wang; D Fisher; M Stevenson
Journal:  Nat Med       Date:  1999-09       Impact factor: 87.241

10.  The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages.

Authors:  M D Miller; M T Warmerdam; I Gaston; W C Greene; M B Feinberg
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

View more
  20 in total

1.  The HIV-1 Nef protein enhances the affinity of reverse transcriptase for RNA in vitro.

Authors:  Cécile Fournier; Jean-Claude Cortay; Caroline Carbonnelle; Chantal Ehresmann; Roland Marquet; Pierre Boulanger
Journal:  Virus Genes       Date:  2002-12       Impact factor: 2.332

2.  Characterization of Nef-CXCR4 interactions important for apoptosis induction.

Authors:  Ming-Bo Huang; Ling Ling Jin; Cleve O James; Mahfuz Khan; Michael D Powell; Vincent C Bond
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

3.  Interaction between Reverse Transcriptase and Integrase Is Required for Reverse Transcription during HIV-1 Replication.

Authors:  Shewit S Tekeste; Thomas A Wilkinson; Ethan M Weiner; Xiaowen Xu; Jennifer T Miller; Stuart F J Le Grice; Robert T Clubb; Samson A Chow
Journal:  J Virol       Date:  2015-09-23       Impact factor: 5.103

4.  Secretion modification region-derived peptide disrupts HIV-1 Nef's interaction with mortalin and blocks virus and Nef exosome release.

Authors:  Martin N Shelton; Ming-Bo Huang; Syed A Ali; Michael D Powell; Vincent C Bond
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

5.  Role of human immunodeficiency virus type 1 integrase in uncoating of the viral core.

Authors:  Marisa S Briones; Charles W Dobard; Samson A Chow
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

6.  Activation of the inositol (1,4,5)-triphosphate calcium gate receptor is required for HIV-1 Gag release.

Authors:  Lorna S Ehrlich; Gisselle N Medina; Mahfuz B Khan; Michael D Powell; Katsuhiko Mikoshiba; Carol A Carter
Journal:  J Virol       Date:  2010-04-28       Impact factor: 5.103

7.  HIV Type 1 Nef is released from infected cells in CD45(+) microvesicles and is present in the plasma of HIV-infected individuals.

Authors:  A D Raymond; T C Campbell-Sims; M Khan; M Lang; M B Huang; V C Bond; M D Powell
Journal:  AIDS Res Hum Retroviruses       Date:  2010-10-21       Impact factor: 2.205

8.  Nef does not affect the efficiency of human immunodeficiency virus type 1 fusion with target cells.

Authors:  Minoru Tobiume; Janet E Lineberger; Christopher A Lundquist; Michael D Miller; Christopher Aiken
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Nef enhances human immunodeficiency virus type 1 infectivity and replication independently of viral coreceptor tropism.

Authors:  Armin Papkalla; Jan Münch; Claas Otto; Frank Kirchhoff
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

10.  Chimeric human immunodeficiency virus type 1 (HIV-1) virions containing HIV-2 or simian immunodeficiency virus Nef are resistant to cyclosporine treatment.

Authors:  Mahfuz Khan; Lingling Jin; Ming Bo Huang; Lesa Miles; Vincent C Bond; Michael D Powell
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.